Nucleus RadioPharma
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
130 Harbour Place Dr Ste 340, Davidson, ...Phone Number
(407) 988-4119Website
www.nucleusrad.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Nucleus RadioPharma
Based in Rochester, MN, Nucleus RadioPharma is a radiopharmaceutical-focused medical device manufacturer.Explore more
Nucleus RadioPharma Org Chart
AR
Chief Commercial Officer (Ad Interim)
JM
Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nucleus RadioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Nucleus RadioPharma
Nucleus RadioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Nucleus RadioPharma had a recent Job posting/layoffs
Check if Nucleus RadioPharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Nucleus RadioPharma recently announced quarterly report
Product Launch: Get notified when Nucleus RadioPharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Nucleus RadioPharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Nucleus RadioPharma has new funding data
Recommended Actions
Find VP level buyers at Nucleus RadioPharma
Find 2 more new buyers
Compare Similar Companies to Nucleus RadioPharma
Compare insights from companies similar to Nucleus RadioPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nucleus RadioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nucleus RadioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nucleus RadioPharma.
Nucleus RadioPharma financials insights
Gather financial insights about Nucleus RadioPharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$6M
2024
Series A
$56M
Nucleus RadioPharma Tech Stack
A closer look at the technologies used by Nucleus RadioPharma
Most Recent Scoops
Open Position
Open Position
Open Position
Left Company
Executive Move
Joseph Warchol, Chief Financial Officer, has recently left the organization and now serves as Chief Financial Officer for Accupac.
Executive Moves, Left Company
Open Position
Nucleus RadioPharma News & Media
Steve Hahn Joins Nucleus RadioPharma as Chief Executive Officer - OncoDaily
Steve Hahn Joins Nucleus RadioPharma as Chief Executive Officer / cancer, Nucleus RadioPharma, OncoDaily, Oncology, Steve HahnNucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints
ROCHESTER, Minn.--(BUSINESS WIRE)--Nucleus RadioPharma today announced the development of two new facilities totaling over 100,000 square feet in Mesa, Arizona and Springhouse, Pennsylvania. These first-of-a-kind facilities will house research, development, and commercial production capabilities under one roof, giving massive time and scale advantage to Nucleus’ partners. This expansion will give the entire radiopharmaceutical industry new capabilities from novel isotope utilization, to broad pNucleus RadioPharma Secures Series A Extension Funding with AstraZeneca Investment
ROCHESTER, Minn.--(BUSINESS WIRE)--Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the closing of a Series A extension round with new investor AstraZeneca (LSE/STO/Nasdaq: AZN). AstraZeneca joins existing investors from GE Healthcare, Mayo Clinic, Eclipse Ventures, Fox Chase Cancer Center, Echo Global Granger Management Mercy Health, and the University of Missouri as Nucleus expands develARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials
CAMBRIDGE, Mass. and ROCHESTER, Minn.--(BUSINESS WIRE)--ARTBIO, Inc. (ARTBIO), a clinical-stage radiopharmaceutical company developing a new class of targeted alpha radioligand therapies (ARTs), and Nucleus RadioPharma Inc. (Nucleus), the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced a strategic manufacturing and supply agreement to support ARTBIO’s therapeutic product manufacturing. Under the terms of the agre
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nucleus RadioPharma
Sign Up For FreeTo access detailed company insights
Based in Rochester, MN, Nucleus RadioPharma is a radiopharmaceutical-focused medical device manufacturer.... Read More
